Cell Therapy leading European CDMO

Cell Therapy: Full dedicated Science & Clinical expertise

More than a classical…

C D M O A

Analytics-driven

Associate

Accelerator

Qualify your Product before patient injection

- - Cell^feature: Therapeutic performance
  - Cell^nature: Identity
  - Cell^secure: Safety

Learn more

Multi-expertise customized approach

- - From Donor tissue to Patients’ injection
  - Regulatory full support
  - Industrialization-focused strategies

Learn more

Ready to use dedicated Platforms

- - Cell^process Platform : PROCESS
  - Cell^analytics Platform : ANALYTICS
  - MSC4^all Platform : Off-the-Shelf MSCs

Our offer at a glance

Bridging the gap between R&D Project and clinical Development

From Regenerative Medicine to Immuno-Oncology,

From Autologous strategy to Allogeneic approach,

From Manufacturing Process, Analytics Bioassays, Quality Control Testing to Stability studies,

your project requirements are our priorities at any time

YOUR Development stages

iPS Cells

Adult Stem Cells

EV & Exoxomes

Engineered Cells (CAR-T, CAR-NK,…)

Aother ATMP

Discovery

Pre-Clinical Development

Clinical Development

NDA Review & Approval

Ph.I
Ph.II
Ph.III

Post-Market monitoring

Ph.IV

OUR Offer

Regulatory coaching

Supply chain & human tissues sourcing

Process & analytical development

Process & analytical validation

Technical Transfer

R&D manufacturing

cGMP manufacturing

QC release & stability studies

About Cell-Easy

Beyond classical Contract Development and Manufacturing Organization (CDMO) offer, we assist our customers not only on GMP manufacturing but from Cell sourcing to Fill&Finish with an expert assistance on regulatory aspects.

Analytics-driven CDMO specialized in Cell Therapy, Cell-Easy provides customized Process Development, GMP Manufacturing and unique Analytical Services in Regenerative Medicine and Immuno-Oncology fields.

Always keeping in mind delays and flexibility to perfectly fit with clients’ expectations.

Discover more